#USA#BreakingNews#News
Alumis CEO Martin Babler inside a lab at his company Nov. 20, 2025, in South San Francisco, Calif. (Dai Sugano/Bay Area News Group)Investors and young scientists are pulling back from biotech, amid broader attacks on science under Trump, industry representatives said.
Originally published at Ethan Baron